Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 35 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale | SELL | $652K 13.5K sh | Apr 3, 2026 |
| 35 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale | SELL | $462K 9,068 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 35 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale | SELL | $462K 9,068 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 35 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale | SELL | $462K 9,068 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 35 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale | SELL | $462K 9,068 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 35 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale | SELL | $521K 10.5K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 35 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale | SELL | $652K 13.5K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 35 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale | SELL | $652K 13.5K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 35 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale | SELL | $521K 10.5K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 35 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale | SELL | $521K 10.5K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 34 | Klimenko PaulinaCHIEF GROWTH OFFICER | Open-market sale | SELL | $99K 12.1K sh | Apr 3, 2026 traded Apr 2, 2026 |
| 31 | Karlsson Jutta CGeneral Counsel | Open-market sale | SELL | $15K 457 sh | Apr 3, 2026 traded Apr 2, 2026 |
| 31 | Rosett MaxChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $1.39M 63.7K sh | Apr 3, 2026 traded Apr 2, 2026 |
| 51 | Zagari RaffaeleDirector | Open-market sale | SELL | $2.62B 11.5K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 38 | Longhito ChristopherFMR SVP & CSCO | Open-market sale | SELL | $186K 5,985 sh | Apr 1, 2026 traded Mar 27, 2026 |
| 38 | Davis ZachEVP & CFO | Open-market sale | SELL | $8.70M 29.0K sh | Apr 1, 2026 traded Mar 30, 2026 |
| 35 | Longhito ChristopherFMR SVP & CSCO | Open-market sale | SELL | $8,857 286 sh | Apr 1, 2026 traded Mar 27, 2026 |
| 35 | Longhito ChristopherFMR SVP & CSCO | Open-market sale | SELL | $26K 819 sh | Apr 1, 2026 traded Mar 23, 2026 |
| 34 | Longhito ChristopherFMR SVP & CSCO | Open-market sale | SELL | $62K 1,984 sh | Apr 1, 2026 traded Mar 27, 2026 |
| 34 | Longhito ChristopherFMR SVP & CSCO | Open-market sale | SELL | $91K 2,927 sh | Apr 1, 2026 traded Mar 27, 2026 |
| 32 | Buonanno Franck JeanVice-President, Global Sales | Open-market sale · 10b5-1 plan | SELL | $24K 10.0K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 32 | Puylaert KevinChief Sales Officer | Open-market sale | SELL | $14.13 3 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 50 | Weaver Robert S.EVP, Government Relations | Open-market sale | SELL | $399K 1,872 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 50 | Morgan RachelEVP General Counsel | Open-market sale | SELL | $668K 3,127 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 47 | Lamattina John LDirector | Open-market sale | SELL | $434K 2,161 sh | Mar 31, 2026 traded Mar 6, 2026 |
| 44 | Degner DennisChief Executive Officer & Pres | Open-market sale | SELL | $693K 15.0K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 40 | Preston Tracy MEVP, CLO & Corporate Secretary | Open-market sale | SELL | $49K 2,736 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 39 | Weitman GarySee Remarks | Open-market sale | SELL | $214K 1,005 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 39 | Bron OlivierCEO, Bloomingdale's | Open-market sale | SELL | $54K 3,051 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 36 | McDowell Erin WSVP & General Counsel | Open-market sale | SELL | $396K 8,250 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 35 | Szabo ShandellDirector | Open-market sale | SELL | $375K 11.7K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 35 | Manor SagitCFO | Open-market sale | SELL | $69K 1,252 sh | Mar 31, 2026 traded Mar 31, 2026 |
| 33 | Huang Michael F.Sr. VP of Clinical Development | Open-market sale | SELL | $128K 4,256 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 33 | Manning MeredithChief Commercial Officer | Open-market sale | SELL | $146K 4,864 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 32 | Furman Carly LisanneCEO NAYX North America | Open-market sale | SELL | $17K 313 sh | Mar 31, 2026 traded Mar 31, 2026 |
| 32 | Tepper OrenCRO | Open-market sale | SELL | $3,991 74 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 30 | Garagic DenisCHIEF TECHNOLOGY OFFICER | Open-market sale | SELL | $84K 15.1K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 50 | Jansen John MDirector | Open-market sale | SELL | $541K 10.5K sh | Mar 30, 2026 traded Mar 27, 2026 |
| 49 | Sheehan William W IIEVP, CHIEF FINANCIAL OFFICER | Open-market sale | SELL | $1.06M 4,883 sh | Mar 30, 2026 traded Mar 26, 2026 |
| 43 | Griscom PaulSVP and Controller | Open-market sale | SELL | $52K 2,919 sh | Mar 30, 2026 traded Mar 27, 2026 |